Ossama Daoui

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 7

Top Topics

Molecular Docking

Tyrosine Kinase

Structure Activity Relationship

Top Venues

Molecules (Basel, Switzerland)

Journal of biomolecular structure & dynamics

Structural chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Khaoula Mkhayar, Ossama Daoui, Rachid Haloui, Kaouakeb Elkhattabi, Abdelmoula El Abbouchi, Samir Chtita, Abdelouahid Samadi, Souad Elkhattabi
Ligand-Based Design of Novel Quinoline Derivatives as Potential Anticancer Agents: An In-Silico Virtual Screening Approach. Molecules (Basel, Switzerland) 29 (2) (2024)
Khaoula Mkhayar, Ossama Daoui, Rachid Haloui, Kaouakeb Elkhattabi, Abdelmoula El Abbouchi, Samir Chtita, Abdelouahid Samadi, Souad Elkhattabi
Ligand-Based Design of Novel Quinoline Derivatives as Potential Anticancer Agents: An In-Silico Virtual Screening Approach. Molecules (Basel, Switzerland) 29 (2) (2024)
Khaoula Mkhayar, Ossama Daoui, Rachid Haloui, Kaouakeb Elkhattabi, Abdelmoula El Abbouchi, Samir Chtita, Abdelouahid Samadi, Souad Elkhattabi
Ligand-Based Design of Novel Quinoline Derivatives as Potential Anticancer Agents: An In-Silico Virtual Screening Approach. Molecules (Basel, Switzerland) 29 (2) (2024)
Khaoula Mkhayar, Ossama Daoui, Rachid Haloui, Kaouakeb Elkhattabi, Abdelmoula El Abbouchi, Samir Chtita, Abdelouahid Samadi, Souad Elkhattabi
Ligand-Based Design of Novel Quinoline Derivatives as Potential Anticancer Agents: An In-Silico Virtual Screening Approach. Molecules (Basel, Switzerland) 29 (2) (2024)
Ossama Daoui, Souad Elkhattabi, Samir Chtita
Rational identification of small molecules derived from 9,10-dihydrophenanthrene as potential inhibitors of 3CL pro enzyme for COVID-19 therapy: a computer-aided drug design approach. Structural chemistry 33 (5) (2022)
Ossama Daoui, Hassan Nour, Oussama Abchir, Souad Elkhattabi, Mohamed Bakhouch, Samir Chtita
A computer-aided drug design approach to explore novel type II inhibitors of c-Met receptor tyrosine kinase for cancer therapy: QSAR, molecular docking, ADMET and molecular dynamics simulations. Journal of biomolecular structure & dynamics (2022)
Mebarka Ouassaf, Ossama Daoui, Sarfaraz Alam, Souad Elkhattabi, Salah Belaidi, Samir Chtita
Pharmacophore-based virtual screening, molecular docking, and molecular dynamics studies for the discovery of novel FLT3 inhibitors. Journal of biomolecular structure & dynamics (2022)